Clinical Trial Update: The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]

View source ↗

Summary

Phase 3 trial of interferon gamma-1b for idiopathic pulmonary fibrosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Pulmonary Fibrosis

Drugs mentioned

• Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: InterMune | Conditions: Idiopathic Pulmonary Fibrosis, Lung Disease | Phase 3 | Status: TERMINATED